![0% sur Pomalidomide Activity Blood 2012 Dispenzieri Blood 2012-02-413161[1][1] terminé](https://s-f.scribdassets.com/images/progress/bar.png?26fe30c55)
DocumentPomalidomide Activity Blood 2012 Dispenzieri Blood 2012-02-413161[1][1]téléversé par
Daniel Drimer- DocumentImmunoglobulin Light Chain Amyloidosis 2011 Update on Diagnosis - Gertztéléversé parDaniel Drimer
- DocumentFlc's and Cardiac Bio Markers - JCO 2011 38 5724 Full[1]téléversé parDaniel Drimer
- DocumentChanges in Serum FLC's to Measure Response -21948_ftp[1]téléversé parDaniel Drimer
- DocumentHow to Manage Primary Amyloidosis Ma Gertztéléversé parDaniel Drimer
- DocumentTroponin Past and Presenttéléversé parDaniel Drimer
- DocumentAmyloidosis_Pathogenesis and New Therapeutic Optionstéléversé parDaniel Drimer
- DocumentDoxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosistéléversé parDaniel Drimer
- DocumentCyBorD Stellar Response Rates in AL AMYtéléversé parDaniel Drimer
Académique Documents
Professionnel Documents
Culture Documents
![Pomalidomide Activity Blood 2012 Dispenzieri Blood 2012-02-413161[1][1]](https://imgv2-1-f.scribdassets.com/img/document/95838022/149x198/6137a601f3/1338803647?v=1)
![Flc's and Cardiac Bio Markers - JCO 2011 38 5724 Full[1]](https://imgv2-2-f.scribdassets.com/img/document/95838005/149x198/baf9fe1818/1338803801?v=1)
![Changes in Serum FLC's to Measure Response -21948_ftp[1]](https://imgv2-2-f.scribdassets.com/img/document/95837998/149x198/a06d2d4300/1398997477?v=1)
